课题基金 / 基金详情

CHEMOEMBOLIZATION AFTER CHEMOTHERAPY & RADIATION TREATMENT IN HEPATIC CANCER

CHEMOEMBOLIZATION AFTER CHEMOTHERAPY & RADIATION TREATMENT IN HEPATIC CANCER
化疗后化疗栓塞
批准号：
6113405
负责人：
CORNELIUS J MCGINN
金额：
$0.02万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6113405
关键词：
clinical research clinical trial phase I combination cancer therapy drug screening /evaluation embolism human subject human therapy evaluation leucovorin liver neoplasms mitomycin C neoplasm /cancer chemotherapy neoplasm /cancer radiation therapy pharmacokinetics

项目摘要

项目成果

CORNELIUS J MCGINN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a Phase I trial of mitomycin C given during hepatic chemoembolization. This treatment is preceded by hepatic artery (HA) FUdR/leucovorin and whole liver radiation therapy. This trial will determine the maximum tolerated dose of mitomycin C chemoembolization after whole liver radiation combined with a single course of HA chemotherapy. Response arte and the control of hepatic tumors will also be assessed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
WHOLE LIVER RADIATION DOSE ESCALATION TRIAL UTILIZING ETHYOL AMIFOSTINE
WHOLE LIVER RADIATION DOSE ESCALATION FOR INTRAHEPATIC CANCERS
LOW DOSE LIVER IRRADIATION WITH HEPATIC ARTERIAL CHEMOTHERAPY FOR CANCER
RADIATION DOSE ESCALATION FOR FOCAL LIVER CANCER
海外基金